It has been a while since we’ve written about healthcare. Our last update was in…
Health / Biology
It’s been over five years since my friend Jonathan Libov and I wrote a blog series on digital healthcare. I revisit these posts every so often – most recently, when I wrote the 2020 edition of our areas of interest in healthcare. Each time I go back, I’m reminded that despite so much development in […]
It has been a while since we’ve written about healthcare. Our last update was in…
We are continually refining our thesis on healthcare, from looking at clinical-grade at-home diagnostics to biotech and…
It’s been over five years since my friend Jonathan Libov and I wrote a blog series on digital healthcare. I revisit these posts every so often – most recently, when I wrote the 2020 edition of our areas of interest in healthcare. Each time I go back, I’m reminded that despite so much development in digital healthcare technology and infrastructure, we have yet to see mainstream scale.
Time and time again, I’ve pondered and written: what is the forcing function for healthcare to be delivered digitally? With so many stakeholders in the healthcare system, could it be patients? Caregivers? Medical care professionals? Clinics and hospital systems? Pharma? Pharmacies? Payers? Government?
Turns out, it’s all of the above working together to fight a global pandemic.
Over the past month, we have seen an acceleration in the adoption of digital healthcare in response to the novel coronavirus. From telemedicine apps to IoT sensors, many digital healthcare products have been built and ready-to-go, but they never quite hit escape velocity. Until now. Virtually overnight, these have become critical tools while we’re sheltering in place. To be specific:
Telemedicine
Not too long ago, telemedicine was considered a convenient alternative to seeing a doctor in-person, although many physicians preferred in-person visits because of reimbursement incentives. But today, telemedicine is used as the primary entry point into the healthcare system, and is extensively used for triage, as well as for non-Covid-19 and non-urgent clinical visits.
Sensors / connected devices
Traditionally embraced by “quantified self” enthusiasts, sensors are now appealing to all consumers as a way to continuously and actively monitor one’s health, i.e. measuring temperature, SpO2 (oxygen saturation), blood pressure, pulse and respiration rates. With fear and uncertainty of a global pandemic, there is a greater urgency for self-care. And the ability to take your own health into your own hands is easy with the purchase of smart watches, thermometers, pulse oximeters, blood pressure cuffs, etc.
The above examples are just the start towards more consumerization of healthcare. As you can imagine, we should also expect at-home test development and usage to rise. While sensors and connected devices give us a view of and monitoring capacity for our health, they are not diagnostics. In fact, there is a big opportunity for Scanwell Health (a V1 portfolio company) to lead the charge in being the next generation LabCorp/Quest Diagnostics in the home. Scanwell’s first product is a self-administered UTI test kit, and while they have been working on other chronic disease detection tests, it’s now all-hands-on-deck to bring the first and only at-home Covid-19 antibody test to the US market.
Finally, given all that is unfolding today, it will be interesting to see the lasting impact and behavioural changes that this pandemic has with respect to how we engage with the healthcare system. What will be the new normal post Covid-19? Some questions that are top-of-mind:
Throughout the course of history, crises have sparked new waves of innovation, and Covid-19 will undoubtedly accelerate the adoption of digital healthcare. Increased digitization will likely change how diagnostics are given, how therapies are provided, how clinicians practice, how we pay for healthcare, and more. When it comes to the healthcare system, “back to normal” will mean a new normal.
Health / Biology, Portfolio, Version One
Shifting healthcare systems from reactive to proactive care is critical – the best outcomes occur when people can take action early, before a condition becomes a diagnosis. That’s why we are excited to announce that we have led a $2.5m pre-seed round for NiaHealth and are thrilled that they are coming out of stealth and […]
We are continually refining our thesis on healthcare, from looking at clinical-grade at-home diagnostics to biotech and…
Over the past year, some of the most interesting and intellectually-stimulating pitches we heard have…